RELYVRIO (sodium phenylbutyrate and taurursodiol), for oral suspension

RELYVRIO is a prescription medicine used for the treatment of amyotrophic lateral sclerosis (ALS) in adults. Brand Name: RELYVRIO (sodium phenylbutyrate and taurursodiol), for oral suspension Initial U.S. Approval: 2022. FDA approved sodium phenylbutyrate and taurursodiol (brand name RELYVRIO) is not (yet) registered or available in India but on request Indian patient can buy RELYVRIO at the lowest price.

RELYVRIO (sodium phenylbutyrate and taurursodiol), for Injection Price In India and Overseas
RELYVRIO (sodium phenylbutyrate and taurursodiol)

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

RELYVRIO (sodium phenylbutyrate and taurursodiol)

Sodium phenylbutyrate/ursodoxicoltaurine is indicated for the treatment of amyotrophic lateral sclerosis (ALS).

RELYVRIO is indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults. The recommended initial dosage of RELYVRIO for oral suspension is 1 packet (3 g sodium phenylbutyrate and 1 g taurursodiol) daily for the first 3 weeks.

Sodium phenylbutyrate/ursodoxicoltaurine, also known as sodium phenylbutyrate/taurursodiol and sold under the brand name Albrioza among others, is a fixed-dose combination medication used for the treatment of amyotrophic lateral sclerosis (ALS). It contains sodium phenylbutyrate and ursodoxicoltaurine (taurursodiol). The combination was approved for medical use in Canada as Albrioza, in June 2022, and in the United States, as Relyvrio, in September 2022.

Drug (Brand / Generic): RELYVRIO / sodium phenylbutyrate and taurursodiol
Current Indications: amyotrophic lateral sclerosis (ALS)
Marketed by:: Amylyx Pharmaceuticals, Inc.
Approval Date: 2022

Dosage forms and strengths of RELYVRIO (sodium phenylbutyrate and taurursodiol)
For oral suspension: 3 g sodium phenylbutyrate and 1 g taurursodiol in singledose packets

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.